169 related articles for article (PubMed ID: 6160092)
1. Induction of antibodies directed against self and altered-self determinants by a synthetic adjuvant, muramyl dipeptide and some of its derivatives.
Löwy I; Leclerc C; Chedid L
Immunology; 1980 Mar; 39(3):441-50. PubMed ID: 6160092
[TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide-induced autoantibody response. II. Age-related change in plaque-forming cell response to bromelain-treated syngeneic erythrocytes.
Fujiwara M; Kariyone A
Int Arch Allergy Appl Immunol; 1981; 66(2):161-72. PubMed ID: 6456997
[TBL] [Abstract][Full Text] [Related]
3. The macrophage, target cell of the synthetic adjuvant muramyl dipeptide.
Fevrier M; Birrien JL; Leclerc C; Chedid L; Liacopoulos P
Eur J Immunol; 1978 Aug; 8(8):558-62. PubMed ID: 359336
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of mitogen-induced polyclonal activation by by a synthetic adjuvant, muramyl dipeptide (MDP).
Löwy I; Leclerc C; Bourgeois E; Chedid L
J Immunol; 1980 Jan; 124(1):320-5. PubMed ID: 6985643
[TBL] [Abstract][Full Text] [Related]
5. Opposite effects of the synthetic adjuvant N-acetyl-muramyl-L-alanyl-D-isoglutamine on the immune response in mice depending on experimental conditions.
Souvannavong V; Adam A
Eur J Immunol; 1980 Aug; 10(8):654-6. PubMed ID: 6995138
[TBL] [Abstract][Full Text] [Related]
6. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
Heymer B; Finger H; Wirsing CH
Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
[TBL] [Abstract][Full Text] [Related]
7. Effect of a synthetic adjuvant on the induction of primary immune responses in T cell-depleted spleen cultures.
Watson J; Whitlock C
J Immunol; 1978 Jul; 121(1):383-9. PubMed ID: 307582
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of the in vivo dinitrophenyl antibody response to the DNP conjugate of L-glutamic acid60-L-alanine30-L-Tyrosine10 (GAT) polymer by a synthetic adjuvant, muramyl dipeptide (MDP): target cells for adjuvant activity and isotypic pattern of MDP-stimulated response.
Lowy I; Theze J; Chedid L
J Immunol; 1980 Jan; 124(1):100-4. PubMed ID: 6965289
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of carrier-specific helper T cell function by the synthetic adjuvant, N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP).
Sugimoto M; Germain RN; Chedid L; Benacerraf B
J Immunol; 1978 Mar; 120(3):980-2. PubMed ID: 344799
[TBL] [Abstract][Full Text] [Related]
10. Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide.
Sone S; Tsubura E
J Immunol; 1982 Sep; 129(3):1313-7. PubMed ID: 7108208
[TBL] [Abstract][Full Text] [Related]
11. Further study on relationship of anti-tuberculous protection to lung granulomata produced by intravenous injections of synthetic 6-0-mycoloyl-N-acetyl-muramyl-L-alanyl-D-isoglutamine with or without specific antigens.
Yamamoto K; Kato K; Kakinuma M; Okuyama H; Azuma I
Immunology; 1982 Jun; 46(2):473-9. PubMed ID: 7044961
[TBL] [Abstract][Full Text] [Related]
12. [Activation of the production of cytotoxic factors by mouse spleen cells exposed to the combined action of lipopolysaccharide and muramyl dipeptide in vitro].
Rakhmilevich AL; Rakhimova MS
Biull Eksp Biol Med; 1988 Apr; 105(4):483-6. PubMed ID: 3359036
[TBL] [Abstract][Full Text] [Related]
13. Strain dependence of muramyl dipeptide-induced LAF(IL 1) release by murine-adherent peritoneal cells.
Abehsira-Amar O; Damais C; Parant M; Chedid L
J Immunol; 1985 Jan; 134(1):365-8. PubMed ID: 3871106
[TBL] [Abstract][Full Text] [Related]
14. Murine immune responses to Salmonella lipopolysaccharide: oral administration of whole bacteria to C3H/HeJ mice induces secondary anti-LPS responses, especially of the IgA isotype.
Jirillo E; Kiyono H; Michalek SM; McGhee JR
J Immunol; 1984 Apr; 132(4):1702-11. PubMed ID: 6366051
[TBL] [Abstract][Full Text] [Related]
15. Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide.
Le Contel C; Temime N; Charron DJ; Parant MA
J Immunol; 1993 May; 150(10):4541-9. PubMed ID: 8482846
[TBL] [Abstract][Full Text] [Related]
16. Modulation of natural killer activity by muramyl peptides: relationship with adjuvant and anti-infectious properties.
Le Garrec Y; Morin A
Nat Immun Cell Growth Regul; 1987; 6(2):65-76. PubMed ID: 2439906
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of an enhanced in vitro immune response by a synthetic adjuvant, muramyl dipeptide.
Specter S; Cimprich R; Friedman H; Chedid L
J Immunol; 1978 Feb; 120(2):487-91. PubMed ID: 413867
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines.
Sarkar K; Das PK
J Immunol; 1997 Jun; 158(11):5357-65. PubMed ID: 9164956
[TBL] [Abstract][Full Text] [Related]
19. Influence of a synthetic adjuvant (MDP) on qualitative and quantitative changes of serum globulins.
Leclerc C; Audibert F; Chedid L
Immunology; 1978 Dec; 35(6):963-70. PubMed ID: 738768
[TBL] [Abstract][Full Text] [Related]
20. The properties of plaque-forming cells from autoimmune and normal strains of mice with specificity for autologous erythrocyte antigens.
Lord EM; Dutton RW
J Immunol; 1975 Nov; 115(5):1199-1205. PubMed ID: 51884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
